Additionally, increased O‐GlcNAcylation activates the mTOR signaling pathway, which is known to be closely associated with cardiomyocyte growth and hypertrophy [310, 311], thereby further aggravating pathological cardiac hypertrophy and HF [312]. This evidence concerns the gene MTOR and cardiac hypertrophy.